Article Details
Retrieved on: 2024-03-11 00:14:18
Tags for this article:
Click the tags to see associated articles and topics
Summary
The Serum Institute of India, led by CEO Adar Poonawalla, is repurposing its COVID-19 vaccine facilities to produce vaccines for malaria and dengue. This shift addresses tropical diseases prevalent in countries like Indonesia.
Article found on: technology.inquirer.net
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here